Skip to content

Author

M. Herrera

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Benefit of upfront combination lipid-lowering therapy in statin-naïve acute coronary syndrome patients with intermediate admission LDL-C and Lp(a)-driven predicted monotherapy failure

The 2025 ESC/EAS Focused Update on the Management of Dyslipidaemias recommends upfront combination therapy (high-intensity statin + ezetimibe) during index hospitalization for acute coronary syndrome (ACS) in lipid-lowering therapy (LLT)-naïve patients unlikely to achieve LDL-C goals with monotherapy. Elevated li...

F. B. Santiago, J. M. Andreu Cayuelas, A. M. Hernandez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.